Table 3. Comparison of clinical characteristics between the discharged and deceased groups.
| Variables | No. of patients | Deceased (n = 16) |
Statistics | p-Value | |
|---|---|---|---|---|---|
| Demographics | |||||
| Male | 61 | 49 (52.8) | 12 (8.2) | 4.170d | 0.041 |
| Female | 58 | 54 (50.2) | 4 (7.8) | ||
| Age | 119 | 58.65 ± 1.21 | 71.81 ± 1.85 | −5.948a | 0.000 |
| Peak temperature | 106 | 38.54 ± 0.06 | 38.73 ± 0.16 | 1.645b | 0.100 |
| Dyspnea | |||||
| Yes | 68 | 54 (58.9) | 14 (9.1) | 5.598d | 0.018 |
| No | 51 | 49 (44.1) | 2 (6.9) | ||
| Fatigue | |||||
| Yes | 72 | 61 (62.3) | 11 (9.7) | 0.526c | 0.468 |
| No | 47 | 42(40.7) | 5(6.3) | ||
| Hematology | |||||
| WBC, ×10⁹/mL | 119 | 6.49 ± 0.37 | 8.22 ± 1.22 | 1.079b | 0.281 |
| Neu, ×10⁹/mL | 119 | 5.21 ± 0.34 | 7.24 ± 1.18 | 2.060a | 0.042 |
| Lym, ×10⁹/mL | 119 | 0.87 ± 0.06 | 0.58 ± 0.07 | −2.551b | 0.11 |
| Mon, ×10⁹/mL | 118 | 0.32 ± 0.02 | 0.35 ± 0.04 | 1.091a | 0.275 |
| NLR | 119 | 8.46 ± 0.83 | 16.16 ± 3.15 | −2.785b | 0.005 |
| LMR | 119 | 3.29 ± 0.22 | 1.64 ± 0.27 | 2.880a | 0.005 |
| Total Tlym, ×106/mL | 109 | 369.89 ± 27.62 | 168.71 ± 27.53 | −3.677b | 0.000 |
| CD4+ Tlym, × 106/mL | 109 | 202.67 ± 15.38 | 115.62 ± 22.70 | −2.741b | 0.006 |
| CD8+ Tlym, × 106/mL | 109 | 150.17 ± 12.37 | 51.35 ± 7.92 | 4.468b | 0.000 |
| Th/Ts | 109 | 1.57 ± 0.10 | 2.45 ± 0.32 | 2.951b | 0.003 |
| CD45, × 106/mL | 109 | 635.82 ± 43.43 | 346.70 ± 57.66 | 3.070b | 0.002 |
| Biochemical analysis | |||||
| AST, U/L | 119 | 32.3 ± 1.8 | 41.9 ± 5.7 | −1.831b | 0.067 |
| ALT, U/L | 119 | 33.6 ± 3.0 | 42.1 ± 9.1 | −1.266b | 0.205 |
| TG, mmol/L | 119 | 1.64 ± 0.07 | 1.57 ± 0.13 | 0.055b | 0.957 |
| Creatine, μM | 119 | 69.76 ± 2.91 | 82.25 ± 0.88 | −1.611a | 0.110 |
| Myo, ng/mL | 111 | 31.80 ± 3.19 | 109.4 ± 23.93 | −10.77b | 0.000 |
| CK, U/L | 112 | 100.33 ± 14.21 | 152.73 ± 30.36 | −2.354b | 0.019 |
| CK-MB, ng/mL | 85 | 2.37 ± 0.44 | 2.89 ± 0.58 | −2.250b | 0.024 |
| Infection indices | |||||
| LDH, U/L | 119 | 312.95 ± 12.54 | 481.94 ± 43.23 | −3.981b | 0.000 |
| CRP, mg/L | 119 | 49.49 ± 3.91 | 67.37 ± 10.38 | −1.753a | 0.080 |
| Coagulation function | |||||
| PCT, ng/mL | 114 | 0.07 ± 0.10 | 0.20 ± 0.24 | −2.610b | 0.009 |
| APTT, s | 119 | 35.06 ± 0.62 | 36.80 ± 0.06 | 1.176b | 0.239 |
| TT, s | 118 | 15.99 ± 0.27 | 15.72 ± 0.43 | −0.830b | 0.407 |
| PT, s | 119 | 13.58 ± 0.31 | 14.19 ± 0.66 | −1.068b | 0.286 |
| INR | 119 | 1.09 ± 0.03 | 1.13 ± 0.05 | −1.169b | 0.242 |
| FIB, g/L | 119 | 4.82 ± 0.85 | 4.64 ± 0.40 | 0.651b | 0.515 |
| D-Dimer, mg/L | 115 | 1.25 ± 0.29 | 3.19 ± 1.27 | −3.003b | 0.003 |
| Blood gas analysis | |||||
| PH | 119 | 7.43 ± 0.01 | 7.41 ± 0.04 | 0.507a | 0.619 |
| PCO2, mmHg | 118 | 38.75 ± 0.47 | 33.80 ± 1.91 | 2.514a | 0.023 |
| PO2, mmHg | 119 | 81.98 ± 3.07 | 55.06 ± 3.49 | −3.837b | 0.000 |
| SO2, % | 119 | 93.88 ± 0.47 | 83.63 ± 4.83 | −3.582b | 0.029 |
| oxygenation, mmHg | 119 | 282.8 ± 13.9 | 124.3 ± 10.6 | 9.072a | 0.000 |
Notes:
t-test.
Mann–Whitney U test.
χ2 test.
Continuity Correction.
NLR, neutrophil lymphocyte ratio; LMR, lymphocyte monocyte ratio.